Institute for Healthier Living Abu Dhabi

What Institute for Healthier Living Abu Dhabi does

Institute for Healthier Living Abu Dhabi (IHLAD) operates as the world's first regulatory-approved Healthy Longevity Medicine Centre, licensed by the Abu Dhabi Department of Health in November 2024. The organization provides precision longevity medicine, advanced diagnostics, and research services targeting individuals seeking proactive health optimization rather than reactive disease treatment, with a secondary engagement model directed at government health entities for population-level research and standards development. IHLAD is structured around three operating pillars: Healthy Longevity Medicine (clinical care), Innovation Hub (technology partnerships), and Population Health Research.

The core technology stack combines AI-driven risk prediction, precision diagnostics, and advanced multi-omics technologies. Proprietary capabilities include AI-enabled risk prediction systems for analyzing individual health data, precision diagnostics for personalized health assessments, and the AD-Omics single-cell analysis platform developed through a joint venture with Singleron Biotechnologies. The Innovation Hub formalizes a partnership model that has already yielded collaborations with the Abu Dhabi Public Health Center (population health MOU), CoreX (population biobank development and AI-driven drug viability prediction, demonstrated at 70% accuracy), and HLMS (regulatory standards development). Patient health data is processed for AI-driven risk prediction and personalized treatment recommendations, and the company is positioning to address a documented gap in which Arabs represent only 0.08% of participants in genetic studies.

Revenue is generated from clinical healthcare services offered on a subscription/recurring basis, with pricing not publicly disclosed. The go-to-market is direct-to-consumer via the Abu Dhabi facility, accessed through website waitlist registration and direct patient consultations. Distribution is concentrated regionally, with operations in the UAE only. The company has not disclosed funding rounds, revenue, or detailed ownership structure beyond a board that includes H.E. Saif Saeed Ghobash as Board Chairman, Talal Al Dhiyebi (Group CEO of Aldar), and other senior Emirati figures, with CEO Dr. Nicole Sirotin leading operations. With 11-50 employees and a 2024 licensing milestone, IHLAD is in early commercialization, with significant infrastructure now in place across regulatory standing, partnerships, and AI-enabled clinical capability.

Name

Institute for Healthier Living Abu Dhabi

Legal name

Institute for Healthier Living Abu Dhabi

Website

https://ihlad.ae

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

IHLAD is the world's first regulatory-approved Healthy Longevity Medicine Centre, operating in Abu Dhabi under Department of Health licensing to deliver AI-driven precision longevity medicine, advanced diagnostics, and population health research to affluent individuals and government health partners in the UAE.

Ownership category

akta.pro rank

Product category

Longevity Medicine

NAICS

Services for the Elderly and Persons with Disabilities (62412), Nursing and Residential Care Facilities (623)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Nursing & Personal Care Facilities (8050)

akta.pro primary industry

Medical Wellness & Longevity (Health Screening, Biohacking, Anti-aging Programs) (THAJAHAI)

akta.pro secondary industry

Healthy Aging & Longevity Lifestyle Coaching (HSADAGAK)

Keywords

• Precision longevity medicine
• Healthy longevity diagnostics
• Lifestyle medicine services
• Preventive healthcare
• Precision medicine research

Headquarters

HQ city

Abu Dhabi

HQ country

United Arab Emirates

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Healthcare Services: Revenue generated from providing personalized healthy longevity medicine services, precision lifestyle medicine consultations, and advanced diagnostics directly to individuals seeking health optimization and disease prevention.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

The Institute for Healthier Living Abu Dhabi (IHLAD) provides personalized healthy longevity medicine services through its licensed clinical facility in Abu Dhabi. It delivers AI-driven diagnostics, precision lifestyle medicine consultations, and proactive health optimization programs targeting biological processes of aging. Its offering is structured around three pillars: Healthy Longevity Medicine (clinical care), Innovation Hub (technology partnerships), and Population Health Research.

Product overview

Institute for Healthier Living Abu Dhabi operates as a healthcare startup pioneering precision lifestyle medicine with a unified platform focused on healthy longevity. The organization is structured around three core pillars: Healthy Longevity Medicine (delivering AI-driven, digitally enabled clinical care using advanced diagnostics), Innovation Hub (driving technology partnerships and cutting-edge solutions), and Population Health Research (collaborating on precision lifestyle medicine and AI-enabled risk prediction). The flagship offering is the world's first licensed Healthy Longevity Medicine Centre, supplemented by the AD-Omics joint venture with Singleron Biotechnologies for multi-omics precision medicine.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthy Longevity Medicine
• Innovation Hub
• Population Health Research

Quantifiable outcome

• AI-driven drug viability prediction with 70% accuracy (CoreX partnership)

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Department of Health Abu DhabicoreStrategic or Co-development PartnerGovernment licensing and regulatory partnership. The Department of Health Abu Dhabi licensed IHLAD as the world's first Healthy Longevity Medicine Centre and collaborated on developing evidence-based licensing standards for healthy longevity medicine facilities in the UAE.
• Healthy Longevity Medicine Society (HLMS)coreStrategic or Co-development PartnerPartnership with HLMS and Abu Dhabi Department of Health to develop and implement the world's first evidence-based licensing standards for Healthy Longevity Medicine facilities. CEO Dr. Nicole Sirotin serves as HLMS Council Member.
• Abu Dhabi Public Health Center (ADPHC)coreStrategic or Co-development PartnerMemorandum of Understanding to explore collaboration opportunities for enabling precise, predictive, preventive and data-driven care and research focused on lifestyle, longevity, and performance for both individuals and population.
• Singleron BiotechnologiescoreStrategic or Co-development PartnerJoint venture 'AD-Omics' established to advance precision medicine in the Middle East through single-cell analysis and multi-omics technologies, combining IHLAD's clinical expertise with Singleron's biotechnology capabilities.
• CoreXminorStrategic or Co-development PartnerAbu Dhabi-based bio-intelligence company working with IHLAD on population biobank development and AI-driven studies analyzing how medications affect different ethnic groups for precision prescriptions in Middle Eastern communities.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Others

• Elysium Health: Elysium Health develops consumer longevity supplements (e.g., Basis/NAD+ boosters) grounded in clinical research. Comparable to IHLAD through its longevity-mission focus, though distributed as consumer products rather than clinical services.
• Thorne: Thorne offers supplements, at-home health tests, and a longevity-focused product line, often in partnership with practitioners. Comparable to IHLAD's lifestyle/wellness layer but as a consumer-product brand rather than a regulated clinical facility.

Direct peers

• Lanserhof: Lanserhof is a European network of luxury medical-wellness and longevity resorts combining diagnostics, lifestyle medicine, and preventive care. It is comparable to IHLAD's premium longevity-medicine positioning and membership-style offering.
• Fountain Life: Fountain Life operates membership-based longevity centers offering advanced diagnostics, whole-body MRI, and AI-driven health assessments. It directly competes with IHLAD in the premium, proactive-health-optimization segment.
• Human Longevity Inc. Founded by Craig Venter, Human Longevity Inc. operates a precision-medicine and longevity-focused practice combining whole-genome sequencing, advanced diagnostics, and AI-driven risk prediction. It is the closest U.S. analog to IHLAD's precision longevity clinic model.
• Privé-Swiss: Privé-Swiss is a Swiss luxury longevity and biohacking clinic offering advanced diagnostics and personalized longevity programs. Comparable to IHLAD in premium positioning and personalized longevity medicine delivery.
• InsideTracker: InsideTracker delivers personalized longevity insights through blood biomarker analysis and AI-driven recommendations. It is comparable to IHLAD's precision diagnostics and lifestyle intervention offering, though without the in-person clinical component.
• Chenot Palace: Chenot operates medical-wellness retreats focused on detox, longevity, and lifestyle medicine. It mirrors IHLAD's wellness-clinic model and target HNW client base in the medical-wellness space.

Emerging players

• Function Health: Function Health provides direct-to-consumer advanced biomarker testing and longitudinal health tracking. It overlaps with IHLAD on the diagnostics + AI-driven risk-prediction layer but does not operate a clinical facility.

Broad incumbents

• Cleveland Clinic Abu Dhabi: A leading multi-specialty hospital in Abu Dhabi where CEO Dr. Nicole Sirotin previously served as Department Chair for 10 years. Operates broadly in the Abu Dhabi healthcare market and serves as a structural reference point for IHLAD's clinical quality bar.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@IHL-AD
• LinkedInlinkedin.com/company/ihlabudhabi
• Instagraminstagram.com/ihl.abudhabi
• Facebookfacebook.com/IHL.AbuDhabi

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Healthier Living Abu Dhabi